[Federal Register Volume 84, Number 223 (Tuesday, November 19, 2019)]
[Notices]
[Pages 63884-63885]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24996]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; 60-Day Comment Request; Information Program
on Clinical Trials: Maintaining a Registry and Results Databank
(National Library of Medicine)
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the requirement of the Paperwork Reduction
Act of 1995 to provide opportunity for public comment on proposed data
collection projects, the National Library of Medicine (NLM), the
National Institutes of Health (NIH), will publish periodic summaries of
proposed projects to be submitted to the Office of Management and
Budget (OMB) for review and approval.
DATES: Comments regarding this information collection are best assured
of having their full effect if received with 60 days of the date of
this publication.
FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data
collection plans and instruments, submit comments in writing, or
request more information on the proposed project, contact: David
Sharlip, Office of Administrative and Management Analysis Services,
National Library of Medicine, Building 38A, Room B2N12, 8600 Rockville
Pike, Bethesda, MD 20894, or call non-toll-free number (301) 827-6361,
or Email your request, including your address to:
[email protected]. Formal requests for additional plans and
instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: Section 3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 requires written comments and/or suggestions from
the public and affected agencies are invited to address one or more of
the following points: (1) Whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) Ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) Ways
to minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Proposed Collection Title: Information Program on Clinical Trials:
Maintaining a Registry and Results Databank, 0925-0586, Expiration
Date: 02/29/2020, EXTENSION, National Library of Medicine (NLM),
National Institutes of Health (NIH).
Need and Use of Information Collection: The National Institutes of
Health operates ClinicalTrials.gov, which was established as a clinical
trial registry under section 113 of the Food and Drug Administration
Modernization Act of 1997 (Pub. L. 105-115) and was expanded to include
a results data bank by Title VIII of the Food and Drug Administration
Amendments Act of 2007 (FDAAA) and by the Clinical Trials Registration
and Results Information Submission regulations at 42 CFR part 11.
ClinicalTrials.gov collects registration and results information for
clinical trials and other types of clinical studies (e.g.,
observational studies and patient registries) with the objectives of
enhancing patient enrollment and providing a mechanism for tracking
subsequent progress of clinical studies to the benefit of public
health. It is widely used by patients, physicians, and medical
researchers; in particular those involved in clinical research. While
many clinical studies are registered and submit results information
voluntarily, 42 CFR part 11 requires the registration of certain
applicable clinical trials of drug, biological, and device products and
the submission of results information for completed applicable clinical
trials of drug, biological, and device products whether or not they are
approved, licensed, or cleared by the Food and Drug Administration.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 1,072,306.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average time
Submission type Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Registration--attachment 2:
Initial..................................... 7,400 1 8 59,200
Updates..................................... 7,400 8 2 118,400
Triggered, voluntary........................ 88 1 8 704
Initial, non-regulated, NIH Policy.......... 657 1 8 5,256
Updates, non-regulated, NIH Policy.......... 657 8 2 10,512
Initial, voluntary and non-regulated........ 11,244 1 8 89,952
Updates, voluntary and non-regulated........ 11,244 8 2 179,904
Results Information Submission--attachment 5:
Initial..................................... 7,400 1 40 296,000
Updates..................................... 7,400 2 10 148,000
Triggered, voluntary--also attachment 2..... 30 1 45 1,350
Initial, non-regulated, NIH Policy.......... 657 1 40 26,280
Updates, non-regulated, NIH Policy.......... 657 2 10 13,140
[[Page 63885]]
Initial, voluntary and non-regulated........ 2,000 1 40 80,000
Updates, voluntary and non-regulated........ 2,000 2 10 40,000
Other:
Certification to delay results--attachment 6 5,150 1 30/60 2,575
Extension request--attachment 7............. 250 1 2 500
Initial, expanded access--attachment 3...... 213 1 2 426
Updates, expanded access--attachment 3...... 213 2 15/60 107
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr
Total................................... .............. 210,037 .............. 1,072,306
----------------------------------------------------------------------------------------------------------------
Dated: November 4, 2019.
David H. Sharlip,
Project Clearance Liaison, National Library of Medicine, National
Institutes of Health.
[FR Doc. 2019-24996 Filed 11-18-19; 8:45 am]
BILLING CODE 4140-01-P